Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks
After two weeks of treatment,GZR18 tablets resulted in an average weight reduction of up to 4.16%,with continued weight loss observed even after discontinuation.